Funding Rounds
Acesion Pharma

Acesion Pharma Series B (2023, $47M)

Acesion Pharma

Therapy to treat atrial fibrillation (AF).

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $47.59M